HopeStage
Back to all studies
CompletedNCT04279522

MOOD Study: Non-Invasive Nerve Stimulation for Depression

About this titleRead the official source — NCT04279522
Device studyAges 18–70United States + Israel
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
La Jolla and 12 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: August 31, 2021
Recruitment status
Completed
Enrollment listed in the registry
124
Sponsor
Neurolief Ltd.
Sponsor type
Other organization
Study type
Device
Intervention type
Device
Locations
United States, Israel
Age range
From 18 Years to 70 Years
Official registry ID
NCT04279522
Official title
Show the full official title

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

La Jolla, United States · Los Angeles, United States · Miami Lakes, United States

9 more locations
  • Tampa, United States
  • Chicago, United States
  • Baltimore, United States
  • Minneapolis, United States
  • Chapel Hill, United States
  • Providence, United States
  • Charleston, United States
  • Houston, United States
  • Tel Aviv, Israel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Neurolief Ltd.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies